24 Biotech Startups in Zürich to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Developer of small molecules to treat novel drug resistance pathways in cancer therapy. |
$20M · Series A | Altos Ventures, BioMedPartners, Redalpine | 1 to 10 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@tolremo.com | ||
Antibody discovery and human immune repertoire analysis platform. |
$27M · Series C | Vesalius Biocapital Partners, Swisscanto Private Equity, Pureos Bioventures | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@memo-therapeutics.com | |
Generative AI platform for protein design and engineering. |
$24M · Series A | Index Ventures, Kindred Capital | 11 to 50 | AI, Biotech | B2B | Zürich, Switzerland | •••••••••••@cradle.bio | |
Gene therapy research to tackle genetic diseases. |
$59M · Series A | Gimv | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@anjarium.com | |
Glycanengineering platform. |
$49M · Series A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@glycoera.com | |
Self-adjuvanting and multi-antigen vaccine technology platform. |
$3M · Series A | AXA Investment Managers, Novo A/S, Adjuvant Capital | 11 to 50 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@lmtbio.com | ||
Producer of ethanol-free perfume pearls. |
$10M · Series A | Helvetica Capital, Zürcher Kantonal Bank, ETH Zurich Foundation | 11 to 50 | Biotech, Manufacturing | B2C | Zürich, Switzerland | •••••••••••@microcaps.ch | |
Clinical biotech firm focused on revolutionizing cell invasion research. |
$4M · Seed | High-Tech Gründerfonds, Verve Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Zürich, Switzerland | •••••••••••@invasight.com | |
Bio-based and biodegradable foam solutions for fast disposables. |
$161k · Pre Seed | Venture Kick | Agritech, Biotech, Energy & Nuclear, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@groamtech.com | ||
Platform offering tools to enhance the development of personalized and precision medicine. |
$20M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Zürich, Switzerland | •••••••••••@bcplatforms.com | ||
Biotechnology platform developing therapies by investing in people and ideas. |
$25M · Series A | 1 to 10 | Health Tech, Fintech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@rejuveron.com | ||
Immunotherapy platform for cancer. |
$330k · Pre Seed | Lightspeed Venture Partners, Gimv, BioMedPartners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@immunostherapeutics.com | |
Developer of an antibody-drug conjugates (ADCs). |
$110k · Pre Seed | btov Partners, Pureos Bioventures, Redalpine | 1 to 10 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@ararisbiotech.com | |
Platform that identifies the ideal treatment for each cancer patient’s disease. |
$7M | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | Zürich, Switzerland | •••••••••••@navignostics.com | |||
Medical robotics company. |
$12M · Series A | 11 to 50 | Biotech | Zürich, Switzerland | •••••••••••@nanoflexrobotics.com | |||
Pathogen detection technology that provides accurate results in under 2 hours. |
$6M · Series B | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B | Zürich, Switzerland | •••••••••••@rqmicro.com | ||
Biotechnology company creating vaccines and immunotherapies. |
$8M · Series B | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@virometix.com | ||
Guided medical devices cardiovascular procedures. |
$4M · Series B | 1 to 10 | Biotech | Zürich, Switzerland | •••••••••••@medyria.com | |||
System improving honey bee health by using heat to combat the varroa mite. |
$1M | 1 to 10 | Climate Tech & Green Tech, Agritech, Hardware, Biotech | B2B | Zürich, Switzerland | •••••••••••@vatorex.ch | ||
Chemicals company producing sustainable chemicals. |
$308k · Pre Seed | 1 to 10 | Biotech, Deep Tech, Proptech & Real Estate, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@biosimo-chemicals.com | ||
Platform for isolating, characterizing, and developing new intestinal microbes. |
N/A | 1 to 10 | Health Tech, Biotech, Deep Tech | Zürich, Switzerland | •••••••••••@pharmabiome.com | |||
Clinical-stage biopharmaceutical company focused on developing innovative medicines. |
N/A | 51 to 100 | Biotech, Deep Tech | Zürich, Switzerland | •••••••••••@molecularpartners.com | |||
Clinical stage biotechnology company developing innovative therapies for rare and debilitating diseases. |
N/A | 11 to 50 | Biotech, Deep Tech | Zürich, Switzerland | •••••••••••@relieftherapeutics.com | |||
Data analytics platform for biotech companies. |
N/A | 1 to 10 | Biotech, Data and Analytics | B2B, SaaS | Zürich, Switzerland | •••••••••••@rivia.ch |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.